Hot International Companies To Own In Right Now

Specialty coatings manufacturer RPM International� (NYSE: RPM  ) announced today its second-quarter dividend of $0.225 per share, the same rate it's paid for the past three quarters after raising the payout almost 5% from $0.215 per share.

The board of directors said the quarterly dividend is payable on July 31 to the holders of record at the close of business on July 12. The increase made last October puts the speciality coatings maker in a rarified group of companies. It marked the 39th consecutive annual dividend increase RPM has made, which it says something less than 0.5% of all 19,000 publicly traded U.S. companies have achieved. Only 47 other companies besides RPM have consecutively paid an increasing annual dividend for this long or longer, it says.

The regular dividend payment equates to a $0.90-per-share annual dividend, yielding 2.8% based on the closing price of RPM international's stock on July 1.

Top 5 Gas Utility Companies For 2015: Mid-America Apartment Communities Inc (MAA)

Mid-America Apartment Communities, Inc., incorporated on September 22, 1993, is a self-administered and self-managed real estate investment trust (REIT). The Company focuses on acquiring, owning and operating apartment communities in the Sunbelt region of the United States. The Company�� segments include Large market same store communities , Secondary market same store communities and Non same store communities and other . As of December 31, 2012 , the Company owned 100% of 160 properties representing 47,809 apartment units. Four properties include retail components with approximately 108,000 square feet of gross leasable area.

As of December 31, 2012 , the Company also had 33.33% ownership interests in Mid-America Multifamily Fund I, LLC, or Fund I, and Mid-America Multifamily Fund II, LLC, or Fund II, which owned two properties containing 626 apartment units and four properties containing 1,156 apartment units, respectively. These apartment communities were located across 13 states. In October 2013, Mid-America Apartment Communities Inc merged with Colonial Properties Trust. In October 2013, Mid America Apartment Communities Inc and Colonial Properties Trust announced the completion of the merger of the two companies.

The Company�� Large market same store communities are generally communities in markets with a population of at least one million and at least 1% of the total public multifamily REIT units that the Company has owned and that has been stabilized for at least a full 12 months and have not been classified as held for sale. Communities are considered stabilized after achieving and maintaining at least 90% occupancy for 90 days. Secondary market same store communities are generally communities in markets with populations of more than one million but less than 1% of the total public multifamily REIT units or markets with populations of less than one million that the Company has owned and that has been stabilized for at least a full 12 months and have not been cl! assified as held for sale. Communities are considered stabilized after achieving and maintaining at least 90% occupancy for 90 days. Non same store communities and other includes recent acquisitions, communities in development or lease-up and communities that have been classified as held for sale. Also included in non same store communities are non multifamily activities which represent less than 1% of the Company's portfolio.

The Company's business is conducted principally through Mid-America Apartments, L.P., which the Company refers to as its Operating Partnership. As of December 31, 2012 , the Company owned or had an ownership interest in 166 multifamily apartment communities in 13 different states. The Company also provides its own in-house leadership development program, which consists of a three-module program followed by two comprehensive case studies, which was developed with the assistance of U.S. Learning, Inc. During the year ended December 31, 2012, the Company purchased 10.6 acres of land and began construction on a new 270-unit community located in the Charleston, South Carolina metropolitan area. As of December 31, 2012 , no units have been delivered for the land in Charleston, South Carolina. During 2012, the Company also purchased 2.0 acres of land and began construction on a new 294-unit community located in Jacksonville, Florida.

Advisors' Opinion:

• [By Rich Duprey]

  Apartment-only real estate investment trust�Mid-America Apartment Communities� (NYSE: MAA  ) once again is snapping up properties, this time announcing Monday that it is adding�multifamily housing operator Colonial Properties Trust (NYSE: CLP  ) to its portfolio in an $8.6 billion transaction.�

• [By Sean Williams]

  Living in a renter's paradise
  The last quarter has been rough on housing and office space real estate investment trusts, with 30-year mortgage rates spiking from less than 3.5% to as high as 4.75% recently. Low lending rates were one of the keys fueling the housing rally higher, so higher lending rates stemming from the potential wind-down of QE3 could serve to stymie growth. Yet for residential-REITs like Mid-America Apartment Communities (NYSE: MAA  ) , the effect would actually be extremely positive.

• [By Marc Bastow]

  Apartment community property real estate investment trust Mid-America Apartment Communities (MAA) raised its quarterly dividend 5% to 73 cents per share, payable on Jan. 31 to shareholders of record as of Jan. 15.
  MAA Dividend Yield: 4.69%

• [By GURUFOCUS]

  Mid-America Apartment Communities Inc. (MAA) is an independent real estate investment trust. Dec. 3, the company increased its quarterly dividend 5% to $0.73 per share. The dividend is payable on Jan. 31, 2014, to shareholders of record on Jan. 15, 2014. The yield based on the new payout is 4.8%.

Hot International Companies To Own In Right Now: Myriad Genetics Inc (MYGN)

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).

As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.

Molecular Diagnostic Tests

The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.

The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.

The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.

Companion Diagnostic Services and Other Revenue

! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.

The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.

Advisors' Opinion:

• [By Luke Jacobi]

  Myriad Genetics (NASDAQ: MYGN) rose 7.70 percent to $25.31 after the company reported that CPT code pricing error should take a 'week or two' to correct. Ladenburg Thalmann upgraded the stock from Neutral to Buy.

Hot International Companies To Own In Right Now: Morgan Stanley(MS)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. It operates in three segments: Institutional Securities, Global Wealth Management Group, and Asset Management. The Institutional Securities segment offers financial advisory services on mergers and acquisitions, divestitures, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers, and leveraged buyouts and takeover defenses, as well as shareholder relations, capital raising, corporate lending, and investments. This segment also engages in sales, trading, financing, and market-making activities, including equity trading, commodities, and interest rates, credit, and currencies, as well as financing services, such as prime brokerage, consolidated clearance, settlement, custody, financing, and portfolio reporting services. The Global Wealth Management Group segment provide s brokerage and investment advisory services covering various investment alternatives comprising equities, options, futures, foreign currencies, precious metals, fixed income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs; education savings programs, financial and wealth planning services, and annuity and insurance products; credit and other lending products; cash management services; retirement services; and trust and fiduciary services. The Asset Management segment offers products and services in equity, fixed income, and alternative investments, such as hedge funds, fund of funds, real estate, private equity, and infrastructure to institutional and retail clients through proprietary and third party distribution channels. This segment also involves in investment and merchant banking activities. The company was founded in 1935 and is headq uartered in New York.

Advisors' Opinion:

• [By Jesse Solomon]

  Of all the major banks, Wells Fargo has been the most beloved by investors as of late. Its stock is up 14% this year, while rivals Bank of America (BAC), JPMorgan (JPM), Citigroup (C), and Goldman Sachs (GS) are all in the red. Morgan Stanley (MS) is the only other large bank in positive territory, but it's only up about a percentage point.

• [By Jonathan Morgan]

  Mediaset SpA (MS) added 2 percent to 3.30 euros after Morgan Stanley increased its target price on the broadcaster controlled by former Italian Prime Minister Silvio Berlusconi to 3.65 euros from 2.15 euros. The brokerage said that an improving advertising market and sustained cost savings will enable the company to reduce its indebtedness.

• [By Chad Fraser]

  The financial gains all come down to two companies, according to FactSet: Bank of America and Morgan Stanley (NYSE: MS), which are up against weak comparisons from a year ago. Set those two aside, and you’re looking at a 0.6% earnings contraction for the sector.

• [By WWW.DAILYFINANCE.COM]

  The broad-based nature of the [manufacturing] gains indicates that the strong second-quarter rebound in economic growth momentum is being sustained.

  "The broad-based nature of the [manufacturing] gains indicates that the strong second-quarter rebound in economic growth momentum is being sustained," said Millan Mulraine, deputy chief economist at TD Securities in New York. The Federal Reserve said factory production jumped 1 percent last month after rising 0.3 percent in June. That was the largest gain since February and reflected increases across all major categories. Auto production surged 10.1 percent, the biggest rise since July 2009. There were also sturdy gains in the production of machinery and computers and electronic goods, which economists said hinted at a pick-up in business investment this quarter. A stronger pace of business investment is needed to ensure sustained economic growth. The economy grew at a 4 percent annual pace in the second quarter and current forecasts peg the growth rate for the third quarter within a range of 2.5 percent to 3 percent. Industrial capacity utilization, a measure of how fully firms are using their resources, last month hit its highest level since February 2008. The solid rise in manufacturing and a 0.3 percent advance in mining output helped to offset a 3.4 percent weather-driven decline in utilities production. That left overall industrial production up 0.4 percent in July. The data had little impact on U.S. financial markets, with traders focusing instead on events in Ukraine. The Ukrainian government said its forces had attacked and partly destroyed a Russian armored column that entered Ukrainian territory overnight. Benign Producer Inflation In a separate report, the New York Fed said its "Empire State" general business conditions index fell to 14.69 this month from 25.60 in July. A reading above zero indicates expansion. Growth in new orders slowed, but a further decline in inventories pointed to an

Hot International Companies To Own In Right Now: Lagardere SCA (MMB)

Lagardere SCA is a France-based media group principally engaged in the publishing sector. The Company operates through four business segments. Lagardere Publishing, the Company's book publishing and e-publishing business carried out under the name of Hachette Livre, publishes educational works, general literature, illustrated books, practical guides and works for the youth market. Lagardere Active encompasses the Company's publishing, audiovisual (radio, television, audiovisual production), digital media and advertising sales brokerage businesses. Lagardere Services takes care of the distribution of the newspaper, communication and leisure. Lagardere Unlimited is the division specialized in the sport industry and entertainment businesses and is active via six subsidiaries: Sportfive, IEC in Sports, Upsolut, Prevent, among others. In April 9, 2013, it sold all of its 7.4% stake in EADS. Advisors' Opinion:

• [By Namitha Jagadeesh]

  BHP Billiton Ltd. (BHP) and Rio Tinto Group, the world�� largest mining companies, advanced at least 3.5 percent. Repsol SA increased the most in a month after saying it discovered natural gas in Algeria. Lagardere SCA (MMB) lost the most in four months after selling its stake in European, Aeronautic, Defence & Space Co.